MercadoLibre Inc. (MELI)vsMedirom Healthcare Technologies Inc (MRM)
MELI
MercadoLibre Inc.
$1,792.63
+1.45%
CONSUMER CYCLICAL · Cap: $90.88B
MRM
Medirom Healthcare Technologies Inc
$1.20
+0.84%
CONSUMER CYCLICAL · Cap: $9.17M
Smart Verdict
WallStSmart Research — data-driven comparison
MercadoLibre Inc. generates 258% more annual revenue ($28.89B vs $8.07B). MELI leads profitability with a 6.9% profit margin vs 0.5%. MRM trades at a lower P/E of 3.0x. MELI earns a higher WallStSmart Score of 62/100 (C+).
MELI
Buy62
out of 100
Grade: C+
MRM
Hold39
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+59.5%
Fair Value
$4981.85
Current Price
$1792.63
$3189.22 discount
Intrinsic value data unavailable for MRM.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Every $100 of equity generates 36 in profit
Revenue surging 44.6% year-over-year
Large-cap with strong market position
Growing faster than its price suggests
Generating 4.8B in free cash flow
Attractively priced relative to earnings
Every $100 of equity generates 53 in profit
Earnings expanding 27.8% YoY
Areas to Watch
Trading at 13.5x book value
6.9% margin — thin
Weak financial health signals
Premium valuation, high expectations priced in
Smaller company, higher risk/reward
0.5% margin — thin
Revenue declined 6.7%
Negative free cash flow — burning cash
Comparative Analysis Report
WallStSmart ResearchBull Case : MELI
The strongest argument for MELI centers on Return on Equity, Revenue Growth, Market Cap. Revenue growth of 44.6% demonstrates continued momentum. PEG of 0.83 suggests the stock is reasonably priced for its growth.
Bull Case : MRM
The strongest argument for MRM centers on P/E Ratio, Return on Equity, EPS Growth.
Bear Case : MELI
The primary concerns for MELI are Price/Book, Profit Margin, Piotroski F-Score. A P/E of 45.5x leaves little room for execution misses.
Bear Case : MRM
The primary concerns for MRM are Market Cap, Profit Margin, Revenue Growth. Debt-to-equity of 8.84 is elevated, increasing financial risk. Thin 0.5% margins leave little buffer for downturns.
Key Dynamics to Monitor
MELI profiles as a hypergrowth stock while MRM is a value play — different risk/reward profiles.
MELI carries more volatility with a beta of 1.49 — expect wider price swings.
MELI is growing revenue faster at 44.6% — sustainability is the question.
MELI generates stronger free cash flow (4.8B), providing more financial flexibility.
Bottom Line
MELI scores higher overall (62/100 vs 39/100) and 44.6% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
MercadoLibre Inc.
CONSUMER CYCLICAL · INTERNET RETAIL · USA
MercadoLibre, Inc. operates online trading platforms in Latin America. The company is headquartered in Buenos Aires, Argentina.
Medirom Healthcare Technologies Inc
CONSUMER CYCLICAL · PERSONAL SERVICES · USA
MEDIROM Healthcare Technologies Inc. provides comprehensive healthcare services in Japan. The company is headquartered in Tokyo, Japan.
Visit Website →Compare with Other INTERNET RETAIL Stocks
Want to dig deeper into these stocks?